Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacira Biosciences, Inc. (PCRX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacira Biosciences, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1396814.
Total stock buying since 2015: $1,511,746.
Total stock sales since 2015: $134,046,095.
Total stock option exercises since 2015: $25,248,807.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 20,833 | $539,598 | 0 | $0 |
2024 | 17,576 | $215,684 | 142,418 | $4,293,651 | 0 | $0 |
2023 | 0 | $0 | 75,177 | $2,936,447 | 23,500 | $712,900 |
2022 | 0 | $0 | 227,928 | $15,306,874 | 252,372 | $6,507,813 |
2021 | 0 | $0 | 400,927 | $28,062,960 | 167,093 | $3,407,228 |
2020 | 2,500 | $91,250 | 691,456 | $39,746,803 | 478,835 | $10,972,788 |
2019 | 1,700 | $66,181 | 180,507 | $7,746,578 | 158,807 | $1,273,560 |
2018 | 9,500 | $457,581 | 284,591 | $12,905,232 | 126,976 | $559,010 |
2017 | 1,100 | $45,316 | 190,915 | $7,882,924 | 173,811 | $872,627 |
2016 | 3,800 | $235,054 | 122,574 | $6,058,768 | 148,000 | $484,035 |
2015 | 6,000 | $400,680 | 104,000 | $8,566,260 | 112,349 | $458,846 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-03-15 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 1,520 | 10.81 | 16,431 |
2021-03-15 | Wicki Andreas | Sale | 10,601 | 73.68 | 781,081 |
2021-03-12 | Wicki Andreas | Sale | 58,754 | 73.10 | 4,294,917 |
2021-03-11 | Wicki Andreas | Sale | 60,574 | 72.70 | 4,403,729 |
2021-03-10 | Wicki Andreas | Sale | 76,480 | 71.78 | 5,489,734 |
2021-03-09 | Wicki Andreas | Sale | 35,137 | 70.90 | 2,491,213 |
2021-03-05 | Hastings Paul J (Director) | Sale | 3,000 | 65.88 | 197,640 |
2021-03-05 | Hastings Paul J (Director) | Option Ex | 3,000 | 13.98 | 41,940 |
2021-03-01 | Longenecker John P Phd (Director) | Sale | 5,000 | 72.26 | 361,300 |
2021-03-01 | Longenecker John P Phd (Director) | Option Ex | 5,000 | 13.98 | 69,900 |
2021-02-03 | Stack David M (CEO and Chairman) | Sale | 21,250 | 71.10 | 1,510,874 |
2021-02-03 | Stack David M (CEO and Chairman) | Option Ex | 21,250 | 10.81 | 229,712 |
2021-02-02 | Stack David M (CEO and Chairman) | Sale | 21,250 | 69.33 | 1,473,262 |
2021-02-02 | Stack David M (CEO and Chairman) | Option Ex | 21,250 | 10.81 | 229,712 |
2021-01-06 | Reinhardt Max (President) | Sale | 110 | 60.81 | 6,689 |
2020-11-16 | Brege Laura (Director) | Sale | 12,000 | 65.95 | 791,400 |
2020-11-16 | Brege Laura (Director) | Option Ex | 12,000 | 13.98 | 167,760 |
2020-11-13 | Reinhardt Max (President) | Sale | 25,000 | 63.09 | 1,577,250 |
2020-11-13 | Reinhardt Max (President) | Option Ex | 25,000 | 42.54 | 1,063,500 |
2020-11-13 | Winston Roy (Chief Clinical Officer) | Sale | 5,000 | 62.00 | 310,000 |
2020-11-13 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 3,000 | 63.81 | 191,430 |
2020-11-13 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 3,000 | 10.81 | 32,430 |
2020-10-16 | Stack David M (CEO and Chairman) | Sale | 30,000 | 55.56 | 1,666,800 |
2020-10-16 | Stack David M (CEO and Chairman) | Option Ex | 30,000 | 10.81 | 324,300 |
2020-10-15 | Stack David M (CEO and Chairman) | Sale | 30,000 | 55.00 | 1,650,000 |
2020-10-15 | Stack David M (CEO and Chairman) | Option Ex | 30,000 | 10.81 | 324,300 |
2020-10-14 | Stack David M (CEO and Chairman) | Sale | 30,000 | 55.53 | 1,665,900 |
2020-10-14 | Stack David M (CEO and Chairman) | Option Ex | 30,000 | 10.81 | 324,300 |
2020-09-25 | Pace Gary W (Director) | Option Ex | 70,000 | 16.67 | 1,166,900 |
2020-09-17 | Reinhardt Max (President) | Sale | 25,420 | 60.01 | 1,525,327 |
2020-09-17 | Reinhardt Max (President) | Option Ex | 25,000 | 42.54 | 1,063,500 |
2020-09-17 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 27,871 | 59.99 | 1,672,120 |
2020-09-17 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 27,871 | 39.76 | 1,108,039 |
2020-09-16 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 3,000 | 60.34 | 181,020 |
2020-09-16 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 3,000 | 10.81 | 32,430 |
2020-09-16 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 27,853 | 59.94 | 1,669,369 |
2020-09-16 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 27,853 | 39.76 | 1,107,323 |
2020-09-15 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 27,853 | 59.41 | 1,654,607 |
2020-09-15 | Williams Kristen Marie (Chief Administrative Officer) | Option Ex | 27,853 | 39.76 | 1,107,323 |
2020-09-09 | Wicki Andreas (Director) | Sale | 2,216 | 62.02 | 137,436 |
2020-08-17 | Stack David M (CEO and Chairman) | Sale | 15,000 | 62.06 | 930,975 |
2020-08-13 | Wicki Andreas (Director) | Sale | 34,904 | 61.47 | 2,145,548 |
2020-08-12 | Wicki Andreas (Director) | Sale | 113,500 | 60.82 | 6,903,070 |
2020-08-11 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 8,180 | 60.50 | 494,890 |
2020-08-11 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 8,180 | 10.34 | 84,581 |
2020-08-11 | Wicki Andreas (Director) | Sale | 106,772 | 61.38 | 6,554,199 |
2020-08-03 | Laranjeira Charles Anthony (SVP, Technical Operations) | Sale | 2,500 | 52.68 | 131,700 |
2020-08-03 | Laranjeira Charles Anthony (SVP, Technical Operations) | Option Ex | 2,500 | 44.10 | 110,250 |
2020-07-15 | Stack David M (CEO and Chairman) | Sale | 12,000 | 56.88 | 682,560 |
2020-06-29 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 6,000 | 49.47 | 296,802 |
2020-06-29 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 6,000 | 10.34 | 62,040 |
2020-06-29 | Laranjeira Charles Anthony (SVP, Technical Operations) | Sale | 60,101 | 51.27 | 3,081,378 |
2020-06-29 | Laranjeira Charles Anthony (SVP, Technical Operations) | Option Ex | 56,250 | 40.95 | 2,303,437 |
2020-06-08 | Stack David M (CEO and Chairman) | Sale | 17,111 | 48.28 | 826,204 |
2020-06-05 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,752 | 48.37 | 84,744 |
2020-06-05 | Brege Laura (Director) | Sale | 2,100 | 48.70 | 102,270 |
2020-06-05 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 5,904 | 48.61 | 286,993 |
2020-06-04 | Mcloughlin Dennis (Chief Commercial Officer) | Sale | 1,447 | 46.33 | 67,040 |
2020-06-04 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 879 | 46.33 | 40,724 |
2020-06-04 | Laranjeira Charles Anthony (SVP, Technical Operations) | Sale | 863 | 46.33 | 39,983 |
2020-06-04 | Reinhart Charles A. Iii (Chief Financial Officer) | Sale | 1,489 | 46.33 | 68,986 |
2020-06-04 | Hastings Paul J (Director) | Sale | 2,025 | 47.46 | 96,106 |
2020-06-04 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 2,402 | 46.33 | 111,287 |
2020-06-04 | Stack David M (CEO and Chairman) | Sale | 14,314 | 46.33 | 663,181 |
2020-05-21 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 2,000 | 45.26 | 90,520 |
2020-05-21 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 2,000 | 10.34 | 20,680 |
2020-05-19 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 2,000 | 42.81 | 85,620 |
2020-05-19 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 2,000 | 10.34 | 20,680 |
2020-03-12 | Longenecker John P Phd (Director) | Option Ex | 3,736 | 1.61 | 6,014 |
2020-03-12 | Pace Gary W (Director) | Option Ex | 21,736 | 4.70 | 102,224 |
2020-03-11 | Winston Roy (Chief Clinical Officer) | Buy | 2,500 | 36.50 | 91,250 |
2020-02-21 | Stack David M (CEO and Chairman) | Option Ex | 35,856 | 3.55 | 127,288 |
2020-02-10 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 3,000 | 48.81 | 146,430 |
2020-02-10 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 3,000 | 10.81 | 32,430 |
2020-02-07 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 170 | 46.81 | 7,957 |
2020-02-07 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 170 | 10.81 | 1,837 |
2020-02-06 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 830 | 46.81 | 38,852 |
2020-02-06 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 830 | 10.81 | 8,972 |
2020-01-15 | Stack David M (CEO and Chairman) | Sale | 25,000 | 43.05 | 1,076,125 |
2020-01-15 | Stack David M (CEO and Chairman) | Option Ex | 25,000 | 10.81 | 270,250 |
2019-12-26 | Stack David M (CEO and Chairman) | Option Ex | 20,000 | 3.55 | 71,000 |
2019-12-23 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,000 | 45.92 | 45,920 |
2019-12-23 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 1,000 | 10.81 | 10,810 |
2019-12-16 | Mcloughlin Dennis (Chief Commercial Officer) | Sale | 3,671 | 45.79 | 168,109 |
2019-12-02 | Longenecker John P Phd (Director) | Sale | 1,300 | 46.13 | 59,971 |
2019-12-02 | Longenecker John P Phd (Director) | Option Ex | 4,000 | 1.61 | 6,440 |
2019-11-20 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,176 | 44.14 | 51,908 |
2019-11-20 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 1,000 | 10.81 | 10,810 |
2019-11-15 | Stack David M (CEO and Chairman) | Sale | 70,000 | 42.81 | 2,996,700 |
2019-11-15 | Stack David M (CEO and Chairman) | Option Ex | 25,000 | 10.81 | 270,250 |
2019-11-11 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 5,000 | 43.59 | 217,950 |
2019-11-11 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 5,000 | 10.57 | 52,875 |
2019-11-08 | Scranton Richard (Chief Scientific Officer) | Sale | 19,448 | 45.00 | 875,160 |
2019-11-08 | Scranton Richard (Chief Scientific Officer) | Option Ex | 19,448 | 18.09 | 351,814 |
2019-10-02 | Stack David M (CEO and Chairman) | Option Ex | 17,000 | 3.55 | 60,350 |
2019-09-18 | Stack David M (CEO and Chairman) | Option Ex | 14,000 | 3.55 | 49,700 |
2019-08-15 | Stack David M (CEO and Chairman) | Sale | 12,849 | 39.33 | 505,351 |
2019-08-15 | Stack David M (CEO and Chairman) | Option Ex | 12,849 | 10.81 | 138,897 |
2019-08-14 | Williams Kristen Marie (Chief Administrative Officer) | Sale | 6,252 | 39.49 | 246,891 |
2019-07-08 | Stack David M (CEO and Chairman) | Sale | 13,115 | 43.13 | 565,715 |
2019-06-11 | Stack David M (CEO and Chairman) | Option Ex | 24,000 | 3.55 | 85,200 |
2019-06-10 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 2,126 | 44.28 | 94,139 |
2019-06-05 | Scranton Richard (Chief Scientific Officer) | Sale | 4,114 | 43.50 | 178,959 |
2019-06-04 | Mcloughlin Dennis (Chief Commercial Officer) | Sale | 1,099 | 42.91 | 47,158 |
2019-06-04 | Winston Roy (Chief Clinical Officer) | Sale | 722 | 42.91 | 30,981 |
2019-06-04 | Scranton Richard (Chief Scientific Officer) | Sale | 4,926 | 42.78 | 210,758 |
2019-06-04 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 967 | 42.91 | 41,493 |
2019-06-04 | Laranjeira Charles Anthony (SVP, Technical Operations) | Sale | 430 | 42.91 | 18,451 |
2019-06-04 | Reinhart Charles A. Iii (Chief Financial Officer) | Sale | 1,106 | 42.91 | 47,458 |
2019-06-04 | Hastings Paul J (Director) | Sale | 782 | 42.66 | 33,360 |
2019-06-04 | Williams Kristen Marie (CAO and General Counsel) | Sale | 2,529 | 42.91 | 108,519 |
2019-06-04 | Stack David M (CEO and Chairman) | Sale | 12,385 | 42.91 | 531,440 |
2019-06-03 | Scranton Richard (Chief Scientific Officer) | Sale | 15,510 | 43.21 | 670,187 |
2019-06-03 | Scranton Richard (Chief Scientific Officer) | Option Ex | 15,510 | 10.66 | 165,414 |
2019-03-06 | Kronenfeld Mark A. (Director) | Buy | 1,700 | 38.93 | 66,181 |
2018-12-18 | Stack David M (CEO and Chairman) | Option Ex | 12,000 | 3.55 | 42,600 |
2018-12-13 | Wicki Andreas | Sale | 8,720 | 46.18 | 402,689 |
2018-12-12 | Wicki Andreas | Sale | 5,807 | 47.84 | 277,801 |
2018-11-19 | Wicki Andreas | Sale | 990 | 47.08 | 46,605 |
2018-11-19 | Pace Gary W (Director) | Buy | 4,500 | 46.18 | 207,810 |
2018-11-16 | Wicki Andreas | Sale | 25,600 | 46.93 | 1,201,356 |
2018-11-15 | Wicki Andreas | Sale | 44,898 | 47.64 | 2,138,850 |
2018-11-15 | Stack David M (CEO and Chairman) | Sale | 15,000 | 47.48 | 712,125 |
2018-11-12 | Wicki Andreas | Sale | 5,478 | 49.83 | 272,979 |
2018-11-09 | Wicki Andreas | Sale | 906 | 50.23 | 45,508 |
2018-11-08 | Wicki Andreas | Sale | 57,339 | 51.13 | 2,931,571 |
2018-11-07 | Pace Gary W (Director) | Buy | 4,000 | 51.29 | 205,160 |
2018-11-02 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,000 | 54.35 | 54,350 |
2018-11-02 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 1,000 | 10.34 | 10,340 |
2018-10-11 | Stack David M (CEO and Chairman) | Option Ex | 45,000 | 2.90 | 130,635 |
2018-09-24 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,000 | 50.70 | 50,700 |
2018-09-24 | Riker Lauren Bullaro (Vice President, Finance) | Option Ex | 1,000 | 10.34 | 10,340 |
2018-08-28 | Kronenfeld Mark A. (Director) | Buy | 1,000 | 44.61 | 44,611 |
2018-08-22 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,667 | 44.48 | 74,148 |
2018-08-15 | Stack David M (CEO and Chairman) | Sale | 33,062 | 47.40 | 1,567,138 |
2018-08-15 | Stack David M (CEO and Chairman) | Option Ex | 14,091 | 8.15 | 114,841 |
2018-08-14 | Williams Kristen Marie (CAO and General Counsel) | Sale | 4,773 | 47.04 | 224,521 |
2018-06-07 | Stack David M (CEO and Chairman) | Sale | 9,791 | 37.08 | 363,050 |
2018-06-06 | Stack David M (CEO and Chairman) | Sale | 8,615 | 35.61 | 306,780 |
2018-06-04 | Scranton Richard (Chief Scientific Officer) | Sale | 1,367 | 33.02 | 45,138 |
2018-06-04 | Weiland Robert J. (Chief Commercial Officer) | Sale | 373 | 33.02 | 12,316 |
2018-06-04 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 801 | 33.02 | 26,449 |
2018-06-04 | Reinhart Charles A. Iii (Chief Financial Officer) | Sale | 708 | 33.02 | 23,378 |
2018-06-04 | Hastings Paul J (Director) | Sale | 771 | 33.90 | 26,136 |
2018-06-04 | Williams Kristen Marie (CAO and General Counsel) | Sale | 2,040 | 33.02 | 67,360 |
2018-05-15 | Stack David M (CEO and Chairman) | Sale | 25,000 | 34.02 | 850,375 |
2018-05-15 | Stack David M (CEO and Chairman) | Option Ex | 25,000 | 8.15 | 203,750 |
2018-01-10 | Stack David M (CEO and Chairman) | Sale | 28,885 | 40.99 | 1,183,909 |
2018-01-10 | Stack David M (CEO and Chairman) | Option Ex | 28,885 | 1.61 | 46,504 |
2017-12-15 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 340 | 43.70 | 14,858 |
2017-11-20 | Jones James B (SVP & Chief Medical Officer) | Sale | 850 | 41.11 | 34,942 |
2017-11-17 | Williams Kristen Marie (CAO and General Counsel) | Sale | 7,857 | 40.00 | 314,280 |
2017-11-17 | Williams Kristen Marie (CAO and General Counsel) | Option Ex | 7,857 | 25.37 | 199,332 |
2017-11-16 | Williams Kristen Marie (CAO and General Counsel) | Sale | 2,143 | 40.01 | 85,741 |
2017-11-16 | Williams Kristen Marie (CAO and General Counsel) | Option Ex | 2,143 | 25.37 | 54,367 |
2017-11-15 | Stack David M (CEO and Chairman) | Sale | 58,885 | 38.65 | 2,275,610 |
2017-11-15 | Stack David M (CEO and Chairman) | Option Ex | 28,885 | 1.61 | 46,504 |
2017-11-10 | Kronenfeld Mark A. (Director) | Buy | 1,000 | 41.60 | 41,603 |
2017-08-22 | Hastings Paul J (Director) | Sale | 1,044 | 36.15 | 37,740 |
2017-08-15 | Williams Kristen Marie (CAO and General Counsel) | Sale | 3,461 | 36.75 | 127,191 |
2017-08-15 | Stack David M (CEO and Chairman) | Sale | 28,885 | 36.37 | 1,050,547 |
2017-08-15 | Stack David M (CEO and Chairman) | Option Ex | 28,885 | 1.61 | 46,504 |
2017-08-08 | Froimson Mark (Director) | Buy | 100 | 37.13 | 3,713 |
2017-07-24 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 1.61 | 24,150 |
2017-06-23 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 1.61 | 24,150 |
2017-06-07 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 1,119 | 44.37 | 49,650 |
2017-06-05 | Jones James B (SVP & Chief Medical Officer) | Sale | 767 | 43.32 | 33,227 |
2017-06-05 | Braunstein Scott (SVP, Strategy & Corp. Dev.) | Sale | 768 | 43.32 | 33,270 |
2017-06-05 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 601 | 43.32 | 26,035 |
2017-06-05 | Scibetta James S (President) | Sale | 1,966 | 43.32 | 85,169 |
2017-06-05 | Williams Kristen Marie (CAO and General Counsel) | Sale | 1,877 | 43.32 | 81,313 |
2017-06-05 | Stack David M (CEO and Chairman) | Sale | 4,311 | 43.32 | 186,756 |
2017-05-15 | Scibetta James S (President) | Sale | 20,000 | 51.20 | 1,024,000 |
2017-05-15 | Scibetta James S (President) | Option Ex | 20,000 | 5.49 | 109,800 |
2017-05-15 | Williams Kristen Marie (CAO and General Counsel) | Sale | 21,041 | 50.86 | 1,070,145 |
2017-05-15 | Williams Kristen Marie (CAO and General Counsel) | Option Ex | 21,041 | 10.19 | 214,470 |
2017-01-17 | Scibetta James S (President) | Sale | 20,000 | 38.68 | 773,600 |
2017-01-17 | Scibetta James S (President) | Option Ex | 20,000 | 3.55 | 71,000 |
2017-01-17 | Stack David M (CEO and Chairman) | Sale | 15,000 | 38.59 | 578,850 |
2017-01-17 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 5.49 | 82,350 |
2016-11-15 | Scibetta James S (President) | Sale | 20,000 | 36.50 | 730,000 |
2016-11-15 | Scibetta James S (President) | Option Ex | 20,000 | 1.61 | 32,200 |
2016-11-15 | Stack David M (CEO and Chairman) | Sale | 15,000 | 37.48 | 562,275 |
2016-11-15 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 5.49 | 82,350 |
2016-10-05 | Stack David M (CEO and Chairman) | Option Ex | 30,000 | 1.61 | 48,300 |
2016-08-15 | Scibetta James S (President) | Sale | 25,000 | 45.21 | 1,130,250 |
2016-08-15 | Scibetta James S (President) | Option Ex | 25,000 | 1.61 | 40,250 |
2016-08-15 | Stack David M (CEO and Chairman) | Sale | 15,000 | 45.32 | 679,800 |
2016-08-15 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 5.49 | 82,350 |
2016-06-07 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 617 | 47.90 | 29,554 |
2016-06-06 | Kronenfeld Mark A. (Director) | Sale | 900 | 46.95 | 42,255 |
2016-06-06 | Riker Lauren Bullaro (Vice President, Finance) | Sale | 321 | 47.20 | 15,150 |
2016-06-06 | Brege Laura (Director) | Sale | 1,000 | 46.95 | 46,950 |
2016-06-06 | Hastings Paul J (Director) | Sale | 1,136 | 46.95 | 53,335 |
2016-06-06 | Williams Kristen Marie (CAO and General Counsel) | Sale | 600 | 47.20 | 28,319 |
2016-04-15 | Stack David M (CEO and Chairman) | Sale | 25,000 | 64.30 | 1,607,375 |
2016-04-15 | Stack David M (CEO and Chairman) | Option Ex | 25,000 | 5.49 | 137,250 |
2016-02-17 | Hastings Paul J (Director) | Sale | 3,000 | 60.00 | 180,000 |
2016-02-17 | Hastings Paul J (Director) | Option Ex | 3,000 | 12.39 | 37,185 |
2016-01-29 | Braunstein Scott (SVP, Strategy & Corp. Dev.) | Buy | 2,000 | 58.92 | 117,840 |
2016-01-27 | Jones James B (SVP & Chief Medical Officer) | Buy | 500 | 62.50 | 31,250 |
2016-01-15 | Stack David M (CEO and Chairman) | Sale | 15,000 | 63.57 | 953,505 |
2016-01-15 | Stack David M (CEO and Chairman) | Option Ex | 15,000 | 1.61 | 24,150 |
2016-01-12 | Jones James B (SVP & Chief Medical Officer) | Buy | 1,000 | 66.00 | 66,000 |
2016-01-12 | Longenecker John P Phd (Director) | Buy | 300 | 66.55 | 19,964 |
2015-11-20 | Hastings Paul J (Director) | Sale | 3,000 | 60.00 | 180,000 |
2015-11-20 | Hastings Paul J (Director) | Option Ex | 3,000 | 10.81 | 32,430 |
2015-10-15 | Stack David M (President, CEO and Chairman) | Sale | 15,000 | 37.83 | 567,450 |
2015-10-15 | Stack David M (President, CEO and Chairman) | Option Ex | 15,000 | 1.61 | 24,150 |
2015-09-11 | Scibetta James S (SVP, Chief Financial Officer) | Buy | 5,000 | 61.37 | 306,850 |
2015-08-17 | Hastings Paul J (Director) | Sale | 3,000 | 60.02 | 180,060 |
2015-08-17 | Hastings Paul J (Director) | Option Ex | 3,000 | 10.81 | 32,430 |
2015-07-15 | Stack David M (President, CEO and Chairman) | Sale | 15,000 | 67.78 | 1,016,700 |
2015-07-15 | Stack David M (President, CEO and Chairman) | Option Ex | 15,000 | 1.61 | 24,150 |
2015-04-15 | Stack David M (President, CEO and Chairman) | Sale | 25,000 | 90.50 | 2,262,475 |
2015-04-15 | Stack David M (President, CEO and Chairman) | Option Ex | 25,000 | 1.61 | 40,250 |
2015-04-10 | Hastings Paul J (Director) | Sale | 2,500 | 88.00 | 220,000 |
2015-04-10 | Hastings Paul J (Director) | Option Ex | 2,500 | 13.98 | 34,950 |
2015-03-17 | Markvicka Taunia (SVP, Chief Commercial Officer) | Option Ex | 8,349 | 5.49 | 45,836 |
2015-03-16 | Riker Lauren Bullaro (Executive Director, Finance) | Sale | 5,000 | 95.34 | 476,700 |
2015-03-16 | Riker Lauren Bullaro (Executive Director, Finance) | Option Ex | 5,000 | 10.34 | 51,700 |
2015-03-13 | Pace Gary W (Director) | Buy | 1,000 | 93.83 | 93,830 |
2015-03-12 | Longenecker John P Phd (Director) | Sale | 3,000 | 95.28 | 285,840 |
2015-03-12 | Longenecker John P Phd (Director) | Option Ex | 3,000 | 29.90 | 89,700 |
2015-02-06 | Scibetta James S (SVP, Chief Financial Officer) | Sale | 15,000 | 111.54 | 1,673,130 |
2015-02-06 | Scibetta James S (SVP, Chief Financial Officer) | Option Ex | 15,000 | 1.61 | 24,150 |
2015-01-15 | Stack David M (President, CEO and Chairman) | Sale | 15,000 | 97.92 | 1,468,755 |
2015-01-15 | Stack David M (President, CEO and Chairman) | Option Ex | 15,000 | 1.61 | 24,150 |
2015-01-12 | Hastings Paul J (Director) | Sale | 2,500 | 94.06 | 235,150 |
2015-01-12 | Hastings Paul J (Director) | Option Ex | 2,500 | 13.98 | 34,950 |
Insider trading activities including stock purchases, stock sales, and option exercises of PCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacira Biosciences, Inc. (symbol PCRX, CIK number 1396814) see the Securities and Exchange Commission (SEC) website.